IXC 0.00% 6.6¢ invex therapeutics ltd

Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-79

  1. 17,505 Posts.
    lightbulb Created with Sketch. 416
    This has been a very large set back and the market has reflected this .
    It will take a while to digest the ramifications.
    One thing that concerned me a little was the need for trial participants to have lumbar punctures and possibly recruitment reluctance however I thought the IIh dehabilating condition and discomfort could offset this .
    Didn’t they have consultants inputting into trial design ? And now we are going to have more consultants figuring out if now even viable .
    Wonder if some directors hang around now ?
    I think this could be a dead duck unfortunately now .
    Even if they go in another direction eg traumatic brain injury it could mean starting from square one .

    ( just my random thoughts)
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.6¢
Change
0.000(0.00%)
Mkt cap ! $4.960M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 100000 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.8¢ 10000 1
View Market Depth
Last trade - 16.12pm 12/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.